Sterne Agee Downgrades Albany Molecular Research (AMRI) to Buy
Tweet
Share
E-mailGet Alerts AMRI Hot Sheet
Price: $21.74 --0%
Rating Summary:
0 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
0 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Sterne Agee downgraded Albany Molecular Research (NASDAQ: AMRI) to Buy with a price target of $7.00.
For an analyst ratings summary and ratings history on Albany Molecular Research click here. For more ratings news on Albany Molecular Research click here.
Shares of Albany Molecular Research closed at $2.45 yesterday.
For an analyst ratings summary and ratings history on Albany Molecular Research click here. For more ratings news on Albany Molecular Research click here.
Shares of Albany Molecular Research closed at $2.45 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- RBC Capital Downgrades Accelerant Holdings (ARX) to Sector Perform
- Lake Street Downgrades SoundThinking (SSTI) to Hold
- Citizens Downgrades SoundThinking (SSTI) to Market Perform
Create E-mail Alert Related Categories
DowngradesRelated Entities
Sterne AgeeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
